Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Nurs Stand ; 39(2): 39-44, 2024 01 31.
Artigo em Inglês | MEDLINE | ID: mdl-38044818

RESUMO

Cellulitis is an acute bacterial infection that affects the deep dermis and surrounding subcutaneous tissue. Although it is a common condition, it is often misdiagnosed because it can mimic a range of conditions that also cause inflamed, red, irritated and painful skin. Such misdiagnoses may lead to unnecessary hospital admissions and antibiotic overuse, with most alternative diagnoses being non-infectious. Undertaking a holistic patient assessment, skin assessment and thorough clinical history is important in the diagnosis of cellulitis, and it is vital to use a collaborative multidisciplinary approach in its acute management and to prevent recurrence. This article defines the term cellulitis and explores its presenting features. The author also discusses the associated risk factors, clinical assessment techniques and effective management strategies, as well as outlining the actions that nurses can take to prevent recurrence.


Assuntos
Antibacterianos , Celulite (Flegmão) , Humanos , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/terapia , Celulite (Flegmão)/induzido quimicamente , Antibacterianos/uso terapêutico , Hospitalização , Erros de Diagnóstico/prevenção & controle , Diagnóstico Diferencial
2.
Trop Biomed ; 40(2): 170-173, 2023 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-37650403

RESUMO

Vibrio cholerae is a gram-negative bacterium synonymous with its namesake disease, cholera. Thus, gastrointestinal symptoms are the norm and V. cholerae is very rarely associated with skin and soft tissue infections. We describe a case of a 63-year-old Chinese woman with multiple medical comorbidities on corticosteroid therapy who developed fever and a painful swelling on her left leg after being pricked by a branch while gardening. There was no abdominal pain, vomiting or diarrhea. A diagnosis of bullous cellulitis was made clinically, and blood was sent for bacteriological culture. A beta-hemolytic commashaped gram-negative bacillus was isolated from the blood. It was also oxidase-positive and produced an acid/alkaline (A/K) reaction on triple sugar iron agar. It was identified biochemically as Vibrio cholerae. After additional testing, it was found to be of the O1 serogroup and Ogawa serotype. The infection resolved following a 10-day course of high-dose co-trimoxazole therapy.


Assuntos
Cólera , Vibrio cholerae O1 , Humanos , Feminino , Pessoa de Meia-Idade , Cólera/diagnóstico , Cólera/tratamento farmacológico , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/tratamento farmacológico , Pele , Dor Abdominal
3.
J Dermatol ; 49(1): 184-189, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34687066

RESUMO

We analyzed the serum zinc levels of 37 patients with 40 phlegmon lesions. The mean serum zinc level was 52.1 ± 16.4 µg/dL. The serum zinc level was negatively correlated with the C-reactive protein (CRP) level (r = -0.66) and white blood cell (WBC) count (r = -0.56). It was also positively correlated with the serum levels of albumin, hemoglobin, and hematocrit (r = 0.57, 0.50, and 0.50, respectively). Patients with serum zinc levels of <60 µg/dL had higher CRP levels and WBC counts (p < 0.005 and p < 0.05, respectively) and lower albumin, hemoglobin, and hematocrit levels (p < 0.001, p < 0.01, and p < 0.01, respectively), and were more likely to be hospitalized (p < 0.05) than those with serum zinc levels of ≥60 µg/dL. Patients with low serum zinc levels were given zinc tablets. Three of the seven patients who developed recurrent phlegmons did not develop any further lesions after taking zinc tablets for >10 months. Of the remaining patients, one only developed a minimal lesion, and another two experienced recurrence twice but did not have any further lesions for 10 and 15 months, respectively. These findings indicate that in patients with phlegmons the serum zinc level is a suitable marker of the severity of infection, and zinc supplementation reduces the risk of further recurrence in patients whose lesions relapse.


Assuntos
Celulite (Flegmão) , Zinco , Biomarcadores , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/tratamento farmacológico , Suplementos Nutricionais , Hemoglobinas , Humanos
4.
Georgian Med News ; (267): 81-84, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28745612

RESUMO

Pemetrexed is a multi-targeted folate antagonists approved for non-small cell lung cancer and other malignancies. Adverse cutaneous reactions have been reported in up to 1/3 of patients treated. A rare cutaneous adverse reaction is pseudocellulitis. We report about a 62-year-old male patient treated with a combination of cisplatin and pemetrexed for non-small cell lung cancer stage IV who developed about 4 months after initiation of treatment painful, non-febrile erythematous lesions on feet and lower legs. There was no lymphadenopathy and no general malaise. Laboratory investigations detected increased level of C-reactive protein but normal values of procalcitonin. A skin biopsy revealed a mild interface dermatitis. Antifolate treatment was stopped and he received oral and topical corticosteroids, compression therapy and supplementation with folate and vitamin B. A complete remission of skin eruptions was achieved. Pemetrexed-induced pseudocellulitis is a possible, but rare complication of treatment that oncologists and dermatologists should know. Systemic antibiosis is unnecessary.


Assuntos
Antineoplásicos/efeitos adversos , Celulite (Flegmão)/diagnóstico , Edema/diagnóstico , Eritema/diagnóstico , Pemetrexede/efeitos adversos , Diagnóstico Diferencial , Edema/induzido quimicamente , Eritema/induzido quimicamente , Humanos , Masculino , Pessoa de Meia-Idade
5.
Transpl Infect Dis ; 19(1)2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27775824

RESUMO

Nontuberculous mycobacterial infections can often occur in individuals with adequate immune function. Such infections typically have cutaneous involvement and are caused by rapidly growing mycobacterium. Other nontuberculous mycobacteria species, like Mycobacterium haemophilum, almost always present as opportunistic infections occurring in severely immunocompromised hosts. Here, we present a complicated and protracted course of diagnosing M. haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.


Assuntos
Antibacterianos/uso terapêutico , Celulite (Flegmão)/tratamento farmacológico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Leucemia Mieloide Aguda/cirurgia , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium haemophilum/isolamento & purificação , Infecções Oportunistas/tratamento farmacológico , Biópsia , Celulite (Flegmão)/complicações , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/microbiologia , Ciprofloxacina/uso terapêutico , Claritromicina/uso terapêutico , Feminino , Doença Enxerto-Hospedeiro/diagnóstico , Doença Enxerto-Hospedeiro/tratamento farmacológico , Humanos , Hospedeiro Imunocomprometido , Terapia de Imunossupressão/efeitos adversos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Extremidade Inferior , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Infecções por Mycobacterium não Tuberculosas/microbiologia , Infecções Oportunistas/complicações , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/microbiologia , Rifabutina/uso terapêutico , Tacrolimo/efeitos adversos , Tacrolimo/uso terapêutico , Doadores não Relacionados
6.
Int J Dermatol ; 55(1): 30-5, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26275796

RESUMO

BACKGROUND: Cellulitis commonly involved lower limbs. This study was carried out to determine the demography, clinical characteristics, risk factors, microbiological aspects, and antibiotics usage in this group of patients in Hospital Kuala Lumpur. METHODS: A total of one hundred and twenty four patients with lower limb cellulitis treated in the Department of Dermatology, Hospital Kuala Lumpur, between January 2008 and May 2013 were included in this study. RESULTS: There were 70 male and 54 female patients, aged between 13 and 87 years (mean 57.23±12.854). Thirty-one of them (25%) had recurrent cellulitis. Fifty-seven (46%) had fever at presentation, 55 (44.4%) had bullous cellulitis. The top risk factors identified were toe web intertrigo (n = 79, 63.7%), hypertension (n=76, 61.3%), obesity (n = 55, 44.4%), and diabetes (n = 55, 44.4%). However, only toe web intertrigo (p = 0.003), peripheral vascular disease (p = 0.01), and varicose veins (p = 0.02) were significantly higher in recurrent cellulitis. Thirty patients (24.2%) were complicated with lipodermatosclerosis, and six (4.8%) had lymphostasis verrucosa cutis. Skin swab cultures were positive in 54 (43.5%) patients, and Pseudomonas sp. was the most frequently identified organism. Mean number of antibiotics given for one episode of cellulitis was 1.7±1. The antibiotics most given were cloxacillin (n=57, 46%) and other penicillins (n = 71, 57%), followed by cephalosporins (n = 40, 32%). CONCLUSION: Identifying clinical characteristics of those at risk may help to prevent recurrence of cellulitis and long-term complications.


Assuntos
Antibacterianos/uso terapêutico , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/tratamento farmacológico , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Celulite (Flegmão)/epidemiologia , Estudos de Coortes , Feminino , Seguimentos , Hospitais Urbanos , Humanos , Extremidade Inferior , Malásia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Recidiva , Estudos Retrospectivos , Medição de Risco , Índice de Gravidade de Doença , Fatores Sexuais , Resultado do Tratamento , Adulto Jovem
7.
Dermatol Online J ; 20(5): 22692, 2014 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-24852785

RESUMO

Dissecting cellulitis (DC) also referred to as to as perifolliculitis capitis abscedens et suffodiens (Hoffman) manifests with perifollicular pustules, nodules, abscesses and sinuses that evolve into scarring alopecia. In the U.S., it predominantly occurs in African American men between 20-40 years of age. DC also occurs in other races and women more rarely. DC has been reported worldwide. Older therapies reported effective include: low dose oral zinc, isotretinoin, minocycline, sulfa drugs, tetracycline, prednisone, intralesional triamcinolone, incision and drainage, dapsone, antiandrogens (in women), topical clindamycin, topical isotretinoin, X-ray epilation and ablation, ablative C02 lasers, hair removal lasers (800nm and 694nm), and surgical excision. Newer treatments reported include tumor necrosis factor blockers (TNFB), quinolones, macrolide antibiotics, rifampin, alitretinoin, metronidazole, and high dose zinc sulphate (135-220 mg TID). Isotretinoin seems to provide the best chance at remission, but the number of reports is small, dosing schedules variable, and the long term follow up beyond a year is negligible; treatment failures have been reported. TNFB can succeed when isotretinoin fails, either as monotherapy, or as a bridge to aggressive surgical treatment, but long term data is lacking. Non-medical therapies noted in the last decade include: the 1064 nm laser, ALA-PDT, and modern external beam radiation therapy. Studies that span more than 1 year are lacking. Newer pathologic hair findings include: pigmented casts, black dots, and "3D" yellow dots. Newer associations include: keratitis-ichthyosis-deafness syndrome, Crohn disease and pyoderma gangrenosum. Older associations include arthritis and keratitis. DC is likely a reaction pattern, as is shown by its varied therapeutic successes and failures. The etiology of DC remains enigmatic and DC is distinct from hidradenitis suppurativa, which is shown by their varied responses to therapies and their histologic differences. Like HS, DC likely involves both follicular dysfunction and an aberrant cutaneous immune response to commensal bacteria, such as coagulase negative staphylococci. The incidence of DC is likely under-reported. The literature suggests that now most cases of DC can be treated effectively. However, the lack of clinical studies regarding DC prevents full understanding of the disease and limits the ability to define a consensus treatment algorithm.


Assuntos
Celulite (Flegmão)/etiologia , Celulite (Flegmão)/terapia , Dermatoses do Couro Cabeludo/etiologia , Dermatoses do Couro Cabeludo/terapia , Dermatopatias Genéticas/etiologia , Dermatopatias Genéticas/terapia , Acitretina/uso terapêutico , Alitretinoína , Antibacterianos/uso terapêutico , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/história , Fármacos Dermatológicos/uso terapêutico , Diagnóstico Diferencial , Estrogênios/uso terapêutico , Etinilestradiol/uso terapêutico , Hidradenite Supurativa/diagnóstico , Hidradenite Supurativa/etiologia , Hidradenite Supurativa/terapia , História do Século XX , Humanos , Terapia a Laser , Linfotoxina-alfa/uso terapêutico , Fototerapia , Radioterapia , Dermatoses do Couro Cabeludo/diagnóstico , Dermatoses do Couro Cabeludo/história , Dermatopatias Genéticas/diagnóstico , Dermatopatias Genéticas/história , Tretinoína/uso terapêutico , Zinco/uso terapêutico
8.
Br J Community Nurs ; 19(1): 12, 14-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24800322

RESUMO

This project was developed to set up a nurse-led service based on the needs of patients diagnosed with 'red legs'. These patients are often wrongly admitted into hospital for treatment of cellulitis. Representatives from the specialties involved in caring for those individuals with red legs were invited to participate with patients to create a stakeholder group whose purpose was to develop integrated care pathways focused on referral criteria, diagnostics and treatment to inform a new nurse-led service. There was a commitment to utilising a number of facilitation techniques and practice-development methods in the progression of the project with the support of the Foundation of Nursing Studies. Much of the prescribed care can be carried out by the patients at home and only 25% patients have required a follow-up appointment within the new service. The service has now been fully commissioned and a secondment opportunity has been developed to lead the new service. Significant savings have been demonstrated and regular revision of the integrated care pathways with all groups, including the patients, will take place.


Assuntos
Prestação Integrada de Cuidados de Saúde/organização & administração , Dermatopatias/diagnóstico , Dermatopatias/enfermagem , Medicina Estatal/organização & administração , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/enfermagem , Dermatite/diagnóstico , Dermatite/enfermagem , Diagnóstico Diferencial , Eczema/diagnóstico , Eczema/enfermagem , Edema/diagnóstico , Edema/enfermagem , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Úlcera da Perna/diagnóstico , Úlcera da Perna/enfermagem , Papel do Profissional de Enfermagem , Guias de Prática Clínica como Assunto , Desenvolvimento de Programas , Estudos Retrospectivos , Esclerodermia Localizada/diagnóstico , Esclerodermia Localizada/enfermagem , Reino Unido , Vasculite/diagnóstico , Vasculite/enfermagem
12.
Artigo em Francês | MEDLINE | ID: mdl-23827272

RESUMO

INTRODUCTION: Third molar extraction is one of the most common surgical procedures in oral and maxillofacial surgery. Infectious complications can be estimated at 3.6% after local anesthesia. OBSERVATION: A 39-year-old female patient, presenting with important swelling of the face and neck after extraction of teeth 28 and 38 after local anesthesia. Clinical and radiographic data led to the diagnosis of facial cellulitis due to a foreign body on the sub angulo-mandibular region. Drainage under general anesthesia was performed and a fragment of anesthesia needle was removed. One month after surgery, the patient was considered cured. DISCUSSION: Breaking an anesthesia needle is a rare accident, which can occur during oral surgery under local anesthesia. Respecting the rules of good practice is essential in preventing this type of complication, especially since forensic rules for dental and oral surgery are becoming stricter.


Assuntos
Anestesia Dentária/efeitos adversos , Anestesia Local/efeitos adversos , Celulite (Flegmão)/etiologia , Corpos Estranhos/complicações , Agulhas/efeitos adversos , Extração Dentária/efeitos adversos , Adulto , Anestesia Local/instrumentação , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/cirurgia , Feminino , Cabeça/cirurgia , Humanos , Pescoço/cirurgia , Extração Dentária/instrumentação
14.
Ann Chir Plast Esthet ; 57(1): 83-6, 2012 Feb.
Artigo em Francês | MEDLINE | ID: mdl-21899940

RESUMO

In recent years, the market for resorbable injectables has been steadily expanding. The European Community's seal of approval (CE) is a sufficient guaranty to get them distributed. These injectables do not require official approval because they are considered to be "implantable medical devices" and not medicines. Macrolane(®)is a hyaluronic acid in gel form (NASHA [non-animal stabilized hyaluronic acid]) and has been on the French market since 2007. It can be injected into all areas except the face. It is highly cross-linked which, while slowing its absorption into the body, can also leave long-lasting residues. We report the first case of cellulitis after injection into the calf by a practitioner in his office.


Assuntos
Celulite (Flegmão)/etiologia , Celulite (Flegmão)/terapia , Ácido Hialurônico/efeitos adversos , Perna (Membro) , Viscossuplementos/efeitos adversos , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Antibacterianos/uso terapêutico , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/tratamento farmacológico , Celulite (Flegmão)/cirurgia , Técnicas Cosméticas/efeitos adversos , Feminino , Humanos , Ácido Hialurônico/administração & dosagem , Doença Iatrogênica , Injeções Intramusculares , Pessoa de Meia-Idade , Sucção , Irrigação Terapêutica , Resultado do Tratamento , Viscossuplementos/administração & dosagem
16.
Surgery ; 149(6): 813-9, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21397287

RESUMO

BACKGROUND: The differential diagnosis of a red breast is extensive and includes both benign and malignant diseases. The literature documents patients who present with a red breast with delays in diagnosis of inflammatory cancer. We recorded our institutional experience prospectively in the evaluation, diagnosis, and treatment of a red breast. METHODS: Data were collected prospectively on patients who presented with a red breast during a 14-month period. A retrospective review of final diagnosis and outcome was then conducted. A PubMed and Ovid Medline literature search were performed. RESULTS: Twenty-two patients presented with a red breast. This number accounted for only 0.6% (22/3,762) of patients evaluated in our breast center during this time period. Final diagnoses were as follows: mastitis in 31.8%, breast abscess in 13.6%, erythematous changes secondary to radiation therapy in 13.6%, cellulitis in 9.1%, and venous hypertension in 9.1%. Other diagnoses included postradiation morphea, benign dermatologic inflammation, Paget disease of the breast, inflammatory breast cancer, and psoriasis (1 patient each). After treatment, 67% (17/22) patients had resolution of their symptoms and 18% (4/22) were improved. Only 1 (4.5%) of 22 patients had a change in diagnosis in a median follow-up of 8.8 months. CONCLUSION: A red breast is an uncommon presenting complaint in patients evaluated at a breast center; however, the differential diagnosis is extensive. With appropriate diagnosis and treatment, most patients will have improvement or resolution of their symptoms. The diagnostic algorithm used by our breast center identified the cause of the red breast correctly in >95% of patients at presentation, and it can serve as a guide to evaluate patients with a red breast. This algorithm is in agreement with National Comprehensive Cancer Network guidelines.


Assuntos
Algoritmos , Doenças Mamárias/diagnóstico , Doenças Mamárias/epidemiologia , Abscesso/diagnóstico , Abscesso/epidemiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/epidemiologia , Diagnóstico Diferencial , Feminino , Humanos , Incidência , Mastite/diagnóstico , Mastite/epidemiologia , Pessoa de Meia-Idade , Estudos Retrospectivos
17.
J Infect Dev Ctries ; 4(8): 521-5, 2010 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-20818105

RESUMO

We report the first case of a post-acupuncture soft tissue infection due to Mycobacterium fortuitum. Two months after finishing an acupuncture treatment session, an immunocompetent 23-year-old woman developed cellulitis at the side of the needle insertions and the acid-fast bacillus was isolated from a closed abscess. The patient was successfully treated with a proper drug combination. We review the literature concerning the infection source and the risks for skin and soft tissue infection due to mycobacteria after acupuncture. The infection source in most cases is unknown but is probably associated with the inadequate sterilization of the needles or the puncture site. We show that these infections are not rare but difficult to diagnose. To avoid delays in the definitive diagnosis, infection with mycobacteria should be considered for skin and soft tissue infections, in particular late-onset infections, which are negative for routine bacterial cultures and without a clinical response to antibiotics used for acute pyogenic infections. Bacterial cultures from this lesion should be maintained for at least six weeks before discharged as negative.


Assuntos
Terapia por Acupuntura/efeitos adversos , Celulite (Flegmão)/diagnóstico , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium fortuitum/isolamento & purificação , Infecções dos Tecidos Moles/diagnóstico , Antibacterianos/uso terapêutico , Celulite (Flegmão)/tratamento farmacológico , Celulite (Flegmão)/microbiologia , Feminino , Humanos , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/microbiologia , Infecções dos Tecidos Moles/tratamento farmacológico , Infecções dos Tecidos Moles/microbiologia , Venezuela , Adulto Jovem
18.
Clin Appl Thromb Hemost ; 16(3): 345-50, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20019019

RESUMO

UNLABELLED: Calciphylaxis is a rare, usually fatal vasculopathic disorder characterized by cutaneous ischemia and necrosis due to calcification of arterioles. Although calciphylaxis is most frequently associated with end-stage renal disease (ESRD) and secondary hyperparathyroidism, it has been reported infrequently among patients on warfarin. No standard treatment has been established for atypical calciphylaxis; however, a potentially beneficial treatment is hyperbaric oxygen therapy (HBOT). A high degree of clinical suspicion, early diagnosis, and understanding the pathophysiology of this disease promotes the optimal management of this extremely morbid and often fatal condition. CASE REPORT: We present a 63-year-old Polynesian woman with biopsy-proven calciphylaxis in the absence of ESRD or elevated serum calcium levels while taking warfarin. Therapeutic dose enoxaparin was substituted for warfarin and she received 40 sessions of HBOT during which lower extremity ulcers resolved. DISCUSSION: Warfarin has been implicated when calciphylaxis presents in an atypical fashion. No guidelines exist for treatment of atypical calciphylaxis in the setting of concomitant warfarin therapy. Up to 80% of calciphylaxis patients die within 1 year of diagnosis. Our patient was changed to low-molecular-weight heparin and received HBOT. CONCLUSION: We present what we believe is the first case of atypical calciphylaxis thought to be attributable to warfarin treated with a therapeutic substitution of anticoagulant and HBOT leading to resolution of cutaneous lesions.


Assuntos
Anticoagulantes/efeitos adversos , Calciofilaxia/induzido quimicamente , Oxigenoterapia Hiperbárica , Úlcera da Perna/etiologia , Varfarina/efeitos adversos , Antibacterianos/uso terapêutico , Anticoagulantes/uso terapêutico , Calciofilaxia/diagnóstico , Calciofilaxia/cirurgia , Calciofilaxia/terapia , Proteínas de Ligação ao Cálcio/antagonistas & inibidores , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/tratamento farmacológico , Terapia Combinada , Desbridamento , Diabetes Mellitus Tipo 2/complicações , Proteínas da Matriz Extracelular/antagonistas & inibidores , Feminino , Humanos , Úlcera da Perna/cirurgia , Úlcera da Perna/terapia , Pessoa de Meia-Idade , Obesidade Mórbida/complicações , Fatores de Risco , Trombofilia/tratamento farmacológico , Varfarina/uso terapêutico , Proteína de Matriz Gla
20.
Stomatologiia (Mosk) ; 87(4): 53-5, 2008.
Artigo em Russo | MEDLINE | ID: mdl-18833139

RESUMO

The duthor detected special changes in oral liquid of macro and trace substances concentrations and their ratio in dynamics of convalescence for 24 patients with odontogenic lymphadenitis complicated by phlegmon. It was established that termination of inflammatory process on earlier terms at addition in complex treatment of this pathology of polyvitaminic complex considerably lowering strontium concentration in oral liquid (Patent RU 2210378 from 20.08.2003).


Assuntos
Celulite (Flegmão) , Assistência Odontológica Integral/métodos , Linfadenite , Odontogênese/fisiologia , Vitaminas/uso terapêutico , Adolescente , Adulto , Idoso , Celulite (Flegmão)/complicações , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/tratamento farmacológico , Feminino , Humanos , Linfadenite/complicações , Linfadenite/diagnóstico , Linfadenite/tratamento farmacológico , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA